Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


venBio Rings In 2013 With Two Company Launches

This article was originally published in The Pink Sheet Daily

Executive Summary

New venture firm venBio, which closed its inaugural $200 million fund in 2010, has begun the new year by unveiling two start ups with very different business propositions.


Related Content

Antibody Approach To CGRP Offers Safer Mode For Migraine Prevention, Labrys Says
Biopharma Dealmaking Quarterly Statistics, Q1 2013
Start-Up Quarterly Statistics, Q1 2013
The A-List: The Trend-Shaping Series A Financings Of 2012
Financings Of The Fortnight: Life Science Venture Funding Not Necessarily On The Decline
The Alnylam Turnaround: What Changed Investors’ Minds?
Migraine Snapshot: Despite Significant Generic Presence, MAP, Allergan, Others See Big Market Potential
Amgen Planned Acquisition Of KAI Would Bring In Replacement For Sensipar


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts